Discover
MDGL
Madrigal Pharmaceuticals, Inc.
514.39
6 x 529.00
1 x 530.50
bid
ask
-
22.56
4.20%
4 @ 04:00 PM
510.38 -4.01 (0.78%)
| Ytd | -11.67% | |
| 1y | 71.37% |
512.75
day range
542.97
284.02
52 week range
615.00
| Open | 539.67 | Prev Close | 536.95 | Low | 512.75 | High | 542.97 | Mkt Cap | 11.86B |
| Vol | 303.74K | Avg Vol | 328.33K | EPS | -13.48 | P/E | N/A | Forward P/E | 41.55 |
| Beta | -1.06 | Short Ratio | 14.11 | Inst. Own | 106.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 508.68 | 200-d Avg | 496.57 | 1yr Est | 678.71 |
MDGL News
prnewswire.com
Ribo y Madrigal alcanzan un primer hito importante en el avance de nuevas terapias con siRNA para MA
/PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK) y su filial Ribocure Pharmaceuticals A
prnewswire.com
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
SUZHOU, China and MÖLNDAL, Sweden, July 1, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (
benzinga.com
B of A Securities Maintains Neutral on Madrigal Pharmaceuticals, Lowers Price Target to $542
B of A Securities analyst Alexandria Hammond maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) wit